1. Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, New York;
2. Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania;
3. Institute for Clinical Immunology, University of Leipzig, Leipzig, Germany;
4. Hamburger Institut für Therapieforschung GmbH, Hamburg, Germany;
5. Fundación Scherbovsky, Mendoza, Argentina;
6. Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Tokyo, Japan;
7. Midwest Chest Consultants, PC, St. Charles, Missouri;
8. Department of Medicine, Pulmonary and Critical Care Medicine, University of Marburg, German Center for Lung Research, Marburg, Germany;
9. Private Practice, Bismarckstraße, Feldbach, Austria;
10. National Heart and Lung Institute, Imperial College London, London, United Kingdom;
11. Novartis Pharma AG, Basel, Switzerland;
12. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey;
13. Novartis Healthcare Pvt. Ltd., Hyderabad, India;
14. Department of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands